EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Association analysis between serum asprosin and metabolic characteristics, Complications in type 2 diabetic patients with different durations

Lijing Ma, Zhengqian Wang, Li Sun, Mina Li, Qianqian Wu, Ming Liu, Minggang Xu, Guoliang Shi, Jianhong Yin, Yan Wang, Linxin Xu iD

Journal of Diabetes Investigation · 2024

DOI: 10.1111/jdi.14313 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Diabetes Investigation, 2024. Verfasst von Lijing Ma und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, First Hospital of Shanxi Medical University, Shanxi Medical University, Taiyuan, Shanxi, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Fibrillin-1, Blood Pressure. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: China Diabetes Research Fund, China Foundation for International Medical Exchanges.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims/Introduction To investigated the association between serum asprosin and metabolic characteristics in type 2 diabetes mellitus patients with different durations. Materials and Methods A total of 436 patients with type 2 diabetes mellitus were enrolled in this study from the community health service center in southeastern Shanxi Province. All the patients were divided into two groups according to their diabetes duration: diabetes duration ≤5 years group ( n = 132) and diabetes duration ≥10 years group ( n = 304). Fasting blood samples were gathered and serum asprosin was tested. Pearson/Spearman correlation analysis was carried out.

Results

Asprosin was comparable between the two groups. Asprosin was positively correlated with systolic blood pressure (SBP), triglycerides, creatinine, serum uric acid and low‐density lipoprotein cholesterol in the diabetes duration ≤5 years group ( P < 0.05). In the diabetes duration ≥10 years group, asprosin was independently correlated with SBP, diastolic blood pressure, body mass index, total cholesterol, triglycerides, low‐density lipoprotein cholesterol, creatinine, serum uric acid, fasting plasma glucose and glycosylated hemoglobin ( P < 0.05). Asprosin was associated with alanine aminotransferase and estimated glomerular filtration rate ( P < 0.05). Multiple linear regression analysis found that SBP and diastolic blood pressure is an independent factor related to serum asprosin in the group with diabetes duration ≤5 years ( P < 0.05). Fasting plasma glucose, SBP, total cholesterol and serum uric acid is an independent factor related to serum asprosin in the group with diabetes duration ≥10 years ( P < 0.05).

Conclusions

Serum asprosin was significantly increased in the group with diabetes duration ≥10 years, and glycosylated hemoglobin, blood pressure and estimated glomerular filtration rate were independent risk factors in long‐duration type 2 diabetes mellitus.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Fibrillin-1Blood PressureHumansMaleFemaleMiddle AgedAgedBiomarkersTime FactorsBlood GlucosePeptide FragmentsGlycated HemoglobinGlomerular Filtration RateUric AcidAdipokines

Stichwörter der Autor:innen

AsprosinDiabetes durationKidney function

Substanzen

Fibrillin-1FBN1 protein, humanBiomarkersBlood GlucosePeptide FragmentsGlycated HemoglobinUric AcidAdipokines

Autor:innen und Institutionen

  • Department of Endocrinology, First Hospital of Shanxi Medical University, Shanxi Medical University, Taiyuan, Shanxi, China.
  • First Clinical Medical College, Shanxi Medical University, Taiyuan, Shanxi, China.
  • Department of Endocrinology, Changzhi Second People's Hospital, Changzhi, China.
  • Clinical Research Center For Endocrine and Metabolic Diseases of Shanxi Medical University, Taiyuan, Shanxi, China.
  • Shanxi Innovation Center for Integrated Management of Hypertension, Hyperlipidemia and Hyperglycemia Correlated with Cardiovascular and Cerebrovascular Diseases, Taiyuan, Shanxi, China.

ORCID-Profile: Linxin Xu

Förderung

  • China Diabetes Research Fund
  • China Foundation for International Medical Exchanges

Zitieren

APA

Ma, L., Wang, Z., Sun, L., Li, M., Wu, Q., Liu, M., Xu, M., Shi, G., Yin, J., Wang, Y., & Xu, L. (2024). Association analysis between serum asprosin and metabolic characteristics, Complications in type 2 diabetic patients with different durations. Journal of Diabetes Investigation. https://doi.org/10.1111/jdi.14313

Vancouver

Ma L, Wang Z, Sun L, Li M, Wu Q, Liu M, et al. Association analysis between serum asprosin and metabolic characteristics, Complications in type 2 diabetic patients with different durations. Journal of Diabetes Investigation. 2024. doi:10.1111/jdi.14313

BibTeX
@article{Ma2024,
  author = {Ma, Lijing and Wang, Zhengqian and Sun, Li and Li, Mina and Wu, Qianqian and Liu, Ming and Xu, Minggang and Shi, Guoliang and Yin, Jianhong and Wang, Yan and Xu, Linxin},
  title = {Association analysis between serum asprosin and metabolic characteristics, Complications in type 2 diabetic patients with different durations},
  journal = {Journal of Diabetes Investigation},
  year = {2024},
  doi = {10.1111/jdi.14313}
}
Kostenlos starten →